Medical News
Secondary Prevention after Ischemic Stroke
New England Journal of Medicine - 18 Feb 2026 10:00
New England Journal of Medicine, Volume 394, Issue 8, Page 784-792, February 19, 2026.
Long QT Syndrome
New England Journal of Medicine - 18 Feb 2026 10:00
New England Journal of Medicine, Volume 394, Issue 8, Page 826-827, February 19, 2026.
One Pivotal Trial, the New Default Option for FDA Approval - Ending the Two-Trial Dogma
New England Journal of Medicine - 18 Feb 2026 10:00
New England Journal of Medicine, Volume 394, Issue 8, Page 815-817, February 19, 2026.
Beta-Blockers after Myocardial Infarction
New England Journal of Medicine - 18 Feb 2026 10:00
New England Journal of Medicine, Volume 394, Issue 8, Page 820-825, February 19, 2026.
Nivolumab for Resected Stage III or IV Melanoma at 9 Years
New England Journal of Medicine - 18 Feb 2026 10:00
New England Journal of Medicine, Volume 394, Issue 8, Page 832-832, February 19, 2026.
Peritoneal Coccidioidomycosis
New England Journal of Medicine - 18 Feb 2026 10:00
New England Journal of Medicine, Volume 394, Issue 8, Page 793-793, February 19, 2026.
Acromegaly
New England Journal of Medicine - 18 Feb 2026 10:00
New England Journal of Medicine, Volume 394, Issue 8, Page 827-830, February 19, 2026.
Revival of Ethionamide by Alpibectir
New England Journal of Medicine - 18 Feb 2026 10:00
New England Journal of Medicine, Volume 394, Issue 8, Page 818-819, February 19, 2026.
Gene Therapy for Nephropathic Cystinosis
New England Journal of Medicine - 18 Feb 2026 10:00
New England Journal of Medicine, Volume 394, Issue 8, Page 809-810, February 19, 2026.
More on Osilodrostat for Bilateral Adrenal Hypercortisolism in Primary Aldosteronism
New England Journal of Medicine - 18 Feb 2026 10:00
New England Journal of Medicine, Volume 394, Issue 8, Page 830-831, February 19, 2026.
Biting the Tail of CAR-T for Relapsed Multiple Myeloma
New England Journal of Medicine - 18 Feb 2026 10:00
New England Journal of Medicine, Volume 394, Issue 8, Page 807-809, February 19, 2026.
An Antibody-Oligonucleotide Conjugate for Myotonic Dystrophy Type 1
New England Journal of Medicine - 18 Feb 2026 10:00
New England Journal of Medicine, Volume 394, Issue 8, Page 763-772, February 19, 2026.
Patient-Controlled Analgesia
New England Journal of Medicine - 18 Feb 2026 10:00
New England Journal of Medicine, Volume 394, Issue 8, February 19, 2026.
A Trial of an Antibody-Oligonucleotide Conjugate
New England Journal of Medicine - 18 Feb 2026 10:00
New England Journal of Medicine, Volume 394, Issue 8, Page 811-814, February 19, 2026.
From Efficacy to Access in Long-Acting HIV Therapy
New England Journal of Medicine - 18 Feb 2026 10:00
New England Journal of Medicine, Ahead of Print.
Enfortumab Vedotin plus Pembrolizumab as Perioperative Therapy
New England Journal of Medicine - 18 Feb 2026 10:00
New England Journal of Medicine, Ahead of Print.
Perioperative Enfortumab Vedotin and Pembrolizumab in Bladder Cancer
New England Journal of Medicine - 18 Feb 2026 10:00
New England Journal of Medicine, Ahead of Print.
Cabotegravir plus Rilpivirine for Persons with HIV and Adherence Challenges
New England Journal of Medicine - 18 Feb 2026 10:00
New England Journal of Medicine, Ahead of Print.